CD8A and cancer: reported that spatial analysis in HNSCC identified interferon-induced MHC-IhiGal9+ CAFs, which create a trap for CD8+ T cells and lead to cancer immune evasion, could be promising targets for more effective immunotherapy for HNSCC (41).